Emerging data in platinum resistance advanced ovarian cancer

Summary

Availability:

On-Demand

Cost:

FREE

Create Account

Recommended

An Evolving Frontier: Endometrial Cancer Treatment

FREE

Immunotherapy and its impact on overall survival in patients with recurrent endometrial cancer

FREE

Phase II PICCOLO Trial Results

Results of Phase II PICCOLO Trial are available. Dr. Angeles Alvarez Secord, PI of PICCOLO Trial, and Dr. Wendel Naumann discuss results of MIRV in Recurrent Platinum-Sensitive Ovarian Cancer with High Folate Receptor-Alpha Expression.

FREE

Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications

FREE

Journal Club: The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial

FREE

IGCS 2024 Endometrial Cancer Master Session

FREE

Journal Club - Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA

FREE

IGCS 2024 Cervical Master Sessions: Moving Forwards

FREE

Symptom Triggered Testing for Ovarian Cancer

Sudha Sundar discusses symptom-triggered testing in ovarian cancer detection, which support that early diagnosis through symptom-triggered testing which could lead to improved diagnosis of early-stage high grade serous ovarian cancer and low-volume disease.

FREE